Amneal Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference

BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE:AMRX) today announced that members of
management will participate in a fireside chat at the RBC Capital
Markets Global Healthcare Conference in New York on Tuesday, May 21,
2019 at 11:00 a.m. Eastern Time.

To access a live webcast of the presentation, visit Amneal’s Investor
Relations Web site at https://investors.amneal.com.
The webcast can also be accessed at the following URL:
http://www.veracast.com/webcasts/rbc/healthcare2019/87314378047.cfm.

An archived version will be available approximately one hour after the
live presentation and can be accessed at the same location for 90 days.

About Amneal

Amneal Pharmaceuticals, Inc. (NYSE:AMRX), headquartered in Bridgewater,
NJ, is an integrated pharmaceutical company focused on developing,
manufacturing and distributing generic, brand and biosimilar products.
The Company has approximately 6,000 employees in its operations in North
America, Asia, and Europe, working together to bring high-quality
medicines to patients primarily within the United States.

Amneal is one of the largest and fastest growing generic pharmaceutical
manufacturers in the United States, with an expanding portfolio of
generic products to include complex dosage forms in a broad range of
therapeutic areas. The Company also markets a portfolio of branded
pharmaceutical products through its Specialty segment focused
principally on central nervous system disorders and parasitic
infections. For more information, visit www.amneal.com.

Contacts

Mark Donohue
(908) 409-6718